Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Convolution-based approaches for in vivo-in vitro correlation modeling

W R Gillespie1

  • 1Office of Clinical Pharmacology and Biopharmaceutics, U.S. Food and Drug Administration, Rockville, Maryland 20857, USA.

Advances in Experimental Medicine and Biology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing Regimens.

CPT: pharmacometrics & systems pharmacology·2017
Same author

The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities.

Pharmaceutical research·1999
Same author

New mathematical implementation of generalized pharmacodynamic models: method and clinical evaluation.

Journal of pharmacokinetics and biopharmaceutics·1997
Same author

Bioavailability assessment from pharmacologic data: method and clinical evaluation.

Journal of pharmacokinetics and biopharmaceutics·1997
Same author

Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.

Journal of pharmacokinetics and biopharmaceutics·1996
Same author

Simultaneous analysis of verapamil and norverapamil enantiomers in human plasma by high-performance liquid chromatography.

Journal of chromatography. B, Biomedical applications·1995

This study presents a direct convolution-based approach for in vivo-in vitro correlation (IVIVC) in extended release (ER) oral dosage forms. This method models in vitro release and plasma drug concentrations directly, simplifying analysis and improving prediction of bioequivalence metrics.

Area of Science:

  • Pharmacokinetics and Drug Delivery
  • Biopharmaceutics
  • Mathematical Modeling

Background:

  • In vivo-in vitro correlation (IVIVC) is crucial for predicting drug performance.
  • Traditional deconvolution methods for IVIVC can be indirect and complex.
  • Extended release (ER) oral dosage forms require robust methods for IVIVC.

Purpose of the Study:

  • To introduce and detail a direct convolution-based modeling approach for IVIVC.
  • To demonstrate the advantages of convolution-based IVIVC over deconvolution methods.
  • To explore various convolution-based IVIVC models and their applicability.

Main Methods:

  • Directly modeling the relationship between in vitro release and plasma drug concentrations.
  • Utilizing convolution integral for drugs with linear, time-invariant disposition.

Related Experiment Videos

  • Developing extended models for nonlinear absorption or presystemic biotransformation.

    • Main Results:

    • Convolution-based IVIVC directly predicts plasma concentration time courses.
    • This approach simplifies interpretation regarding bioequivalence metrics.
    • Methods can be constructed without requiring IV, oral solution, or IR reference doses.

    Conclusions:

    • Convolution-based IVIVC offers a more direct and interpretable alternative to deconvolution.
    • The approach is adaptable to various drug properties and study designs.
    • This modeling strategy enhances the understanding of in vitro release impact on in vivo drug behavior.